The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Comparison of once-daily insulin detemir with NPH insulin added to a regimen of oral antidiabetic drugs in poorly Controlled Type 2 Diabetes
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Stratton, I. M. (2000) · BMJ · doi:10.1136/bmj.321.7258.405 · Cited by 9,059
Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes
Gæde, P., Vedel, P., Larsen, N., Jensen, G. V. H., Parving, H.-H., & Pedersen, O. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa021778 · Cited by 4,378
Ohkubo, Y., Kishikawa, H., Araki, E., Miyata, T., Isami, S., Motoyoshi, S., Kojima, Y., Furuyoshi, N., & Shichiri, M. (1995) · Diabetes Research and Clinical Practice · doi:10.1016/0168-8227(95)01064-k · Cited by 3,079
Riddle (2003) · doi:10.2337/diacare.26.11.3080 · Cited by 1,479
Global guideline for type 2 diabetes
(2014) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2012.10.001 · Cited by 1,064
Heine, R. J., Van Gaal, L. F., Johns, D., Mihm, M. J., Widel, M. H., Brodows, R. G., & for the GWAA Study Group* (2005) · Annals of Internal Medicine · doi:10.7326/0003-4819-143-8-200510180-00006 · Cited by 795
Hermansen, K., Davies, M., Derezinski, T., Martinez Ravn, G., Clauson, P., Home, P., & on behalf of the Levemir Treat-to-Target Study Group (2006) · Diabetes Care · doi:10.2337/dc05-1365 · Cited by 627
Self-citationInitiating Insulin Therapy in Type 2 Diabetes
Raskin, P., Allen, E., Hollander, P., Lewin, A., Gabbay, R. A., Hu, P., Bode, B., Garber, A., & for the INITIATE Study Group (2005) · Diabetes Care · doi:10.2337/diacare.28.2.260 · Cited by 560
When oral agents fail: practical barriers to starting insulin
Korytkowski, M. (2002) · International Journal of Obesity · doi:10.1038/sj.ijo.0802173 · Cited by 448
The Mechanism of Protraction of Insulin Detemir, a Long-Acting, Acylated Analog of Human Insulin
Havelund, S., Plum, A., Ribel, U., Jonassen, I., Vølund, A., Markussen, J., & Kurtzhals, P. (2004) · Pharmaceutical Research · doi:10.1023/b:pham.0000036926.54824.37 · Cited by 429
Hermansen, K., Fontaine, P., Kukolja, K. K., Peterkova, V., Leth, G., & Gall, M.-A. (2004) · Diabetologia · doi:10.1007/s00125-004-1365-z · Cited by 365
Fritsche, A., Schweitzer, M. A., Hring, H.-U., & and the 4001 Study Group* (2003) · Annals of Internal Medicine · doi:10.7326/0003-4819-138-12-200306170-00006 · Cited by 331
Improvement of Glycemic Control in Subjects With Poorly Controlled Type 2 Diabetes
Davies, M., Storms, F., Shutler, S., Bianchi-Biscay, M., Gomis, R., & for the AT.LANTUS Study Group (2005) · Diabetes Care · doi:10.2337/diacare.28.6.1282 · Cited by 314
Vague, P., Selam, J.-L., Skeie, S., De Leeuw, I., Elte, J. W. F., Haahr, H., Kristensen, A., & Draeger, E. (2003) · Diabetes Care · doi:10.2337/diacare.26.3.590 · Cited by 294
Haak, T., Tiengo, A., Draeger, E., Suntum, M., & Waldhäusl, W. (2005) · Diabetes, Obesity and Metabolism · doi:10.1111/j.1463-1326.2004.00373.x · Cited by 277
Plank, J., Bodenlenz, M., Sinner, F., Magnes, C., Görzer, E., Regittnig, W., Endahl, L. A., Draeger, E., Zdravkovic, M., & Pieber, T. R. (2005) · Diabetes Care · doi:10.2337/diacare.28.5.1107 · Cited by 271
Home, P., Bartley, P., Russell-Jones, D., Hanaire-Broutin, H., Heeg, J.-E., Abrams, P., Landin-Olsson, M., Hylleberg, B., Lang, H., Draeger, E., et al. (2004) · Diabetes Care · doi:10.2337/diacare.27.5.1081 · Cited by 254
Insulin detemir and insulin aspart: a promising basal-bolus regimen for type 2 diabetes
Rašlová, K., Bogoev, M., Raz, I., Leth, G., Gall, M.-A., & Hâncu, N. (2004) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2004.03.003 · Cited by 195
Russell-Jones, D., Simpson, R., Hylleberg, B., Draeger, E., & Bolinder, J. (2004) · Clinical Therapeutics · doi:10.1016/s0149-2918(04)90072-0 · Cited by 194
Kennedy, L., Herman, W. H., Strange, P., Harris, A., & for the GOAL A1C Team (2006) · Diabetes Care · doi:10.2337/diacare.29.01.06.dc05-1058 · Cited by 189
De Leeuw, I., Vague, P., Selam, J. ‐., Skeie, S., Lang, H., Draeger, E., & Elte, J. W. F. (2005) · Diabetes, Obesity and Metabolism · doi:10.1111/j.1463-1326.2004.00363.x · Cited by 179
Malone, J. K., Kerr, L. F., Campaigne, B. N., Sachson, R. A., & Holcombe, J. H. (2004) · Clinical Therapeutics · doi:10.1016/j.clinthera.2004.12.015 · Cited by 167
Benedetti, M. M., Humburg, E., Dressler, A., Ziemen, M., & for the 3002 Study Group (2003) · Hormone and Metabolic Research · doi:10.1055/s-2003-39080 · Cited by 149
Insulin detemir: from concept to clinical experience
Home, P., & Kurtzhals, P. (2006) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.7.3.325 · Cited by 143
Pieber, T. R., Draeger, E., Kristensen, A., & Grill, V. (2005) · Diabetic Medicine · doi:10.1111/j.1464-5491.2005.01545.x · Cited by 122
Therapy in Type 2 Diabetes: Insulin Glargine vs. NPH Insulin Both in Combination with Glimepiride
Eliaschewitz, F. G., Calvo, C., Valbuena, H., Ruiz, M., Aschner, P. J., Villena, J. E., Ramirez, L. A., & Jiménez, J. T. (2006) · Archives of Medical Research · doi:10.1016/j.arcmed.2005.10.015 · Cited by 109
Standl, E., Lang, H., & Roberts, A. (2004) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2004.6.579 · Cited by 99
HOE 901/2004 Study Investigators Group (2003) · Diabetic Medicine · doi:10.1046/j.1464-5491.2003.00999.x · Cited by 61
Standl, E., Maxeiner, S., & Raptis, S. (2006) · Hormone and Metabolic Research · doi:10.1055/s-2006-925222 · Cited by 47
Luzio, S. D., Beck, P., & Owens, D. R. (2003) · Hormone and Metabolic Research · doi:10.1055/s-2003-41625 · Cited by 38
Overcoming obstacles: new management options
Heinemann, L. (2004) · European Journal of Endocrinology · doi:10.1530/eje.0.151t023 · Cited by 30
Cited by
Addition of Biphasic, Prandial, or Basal Insulin to Oral Therapy in Type 2 Diabetes
Holman, R. R., Thorne, K. I., Farmer, A. J., Davies, M. J., Keenan, J. F., Paul, S., & Levy, J. C. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa075392 · Cited by 710
Rosenstock, J., Davies, M., Home, P. D., Larsen, J., Koenen, C., & Schernthaner, G. (2008) · Diabetologia · doi:10.1007/s00125-007-0911-x · Cited by 447
“Insulin detemir was associated with a modest relative reduction in weight gain, consistent with observations in previous comparisons of this analogue with NPH in type 2 diabetes [12, 13, 19, 20].”
ResultHypoglycemia: The neglected complication
Kalra, S., Mukherjee, J. J., Venkataraman, S., Bantwal, G., Shaikh, S., Saboo, B., Das, A. K., & Ramachandran, A. (2013) · Indian Journal of Endocrinology and Metabolism · doi:10.4103/2230-8210.117219 · Cited by 255
Long-acting insulin analogues versus NPH human insulin in type 2 diabetes
Monami, M., Marchionni, N., & Mannucci, E. (2008) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2008.04.007 · Cited by 211
Insulin therapy for type 2 diabetes.
Swinnen, S. G., Hoekstra, J. B., & DeVries, J. H. (2009) · Diabetes Care · doi:10.2337/dc09-s318 · Cited by 181
Metadata
- Authors
- Philis-Tsimikas, A., Charpentier, G., Clauson, P., Ravn, G. M., Roberts, V. L., & Thorsteinsson, B.
- Venue
- Clinical Therapeutics
- Publisher
- Elsevier BV
- Published
- 2006-10
- Volume
- 28
- Issue
- 10
- Pages
- 1569-1581
- ISSN
- 0149-2918 (ISSN-L)
- OpenAlex
- W2165423692
- Cited by
- 278
- References
- 31
- FWCI
- 16.74
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.